Related Experiment Video
Updated: Jun 29, 2025

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
Published on: September 5, 2017
Urinary metabolic characterization of advanced tuberculous meningitis cases in a South African paediatric population
Simon Isaiah1, Du Toit Loots1, Mari van Reenen1
1Human Metabolomics, Faculty of Natural and Agricultural Sciences, North-West University, Potchefstroom, South Africa.
Insights
This study identified 29 urinary metabolites in children with tuberculous meningitis (TBM), revealing key metabolic pathway disruptions. These findings offer potential biomarkers for diagnosing pediatric TBM non-invasively.
Area of Science:
- * Biochemistry and Molecular Biology
- * Pediatric Infectious Diseases
- * Metabolomics
Background:
- * Tuberculous meningitis (TBM) is a severe form of tuberculosis with significant neurological complications and mortality, particularly in children.
- * Limited understanding exists regarding the metabolic alterations associated with pediatric TBM.
- * Non-invasive diagnostic markers are crucial for early TBM detection in children.
Purpose of the Study:
- * To identify characteristic urinary metabolic markers differentiating severe pediatric TBM cases from controls.
- * To investigate the metabolic pathways affected in pediatric TBM.
- * To establish a potential biosignature for pediatric TBM diagnosis.
Main Methods:
- * Untargeted 1H NMR-based metabolomics analysis of urine samples from pediatric TBM cases (n=13) and controls (n=44).
- * Statistical analysis using MetaboAnalyst (v5.0) to identify significant metabolites.
- * Categorization of identified metabolites into affected metabolic pathways.
Main Results:
- * Identification of 29 characteristic urinary metabolites in pediatric TBM patients.
- * Six dysregulated metabolic pathways were identified: tryptophan catabolism, amino acid metabolism, energy production, gut microbiota metabolism, ketoacidosis, and nitrogen excretion.
- * These metabolites provide insights into the metabolic signature of advanced TBM in children.
Conclusions:
- * A distinct urinary metabolic profile characterizes pediatric TBM.
- * The identified metabolites and pathways can serve as potential non-invasive biomarkers for pediatric TBM.
- * This research offers novel biological insights into TBM's metabolic impact on children.
Abstract:
Tuberculous meningitis (TBM) is a severe form of tuberculosis with high neuro-morbidity and mortality, especially among the paediatric population (aged ≤12 years). Little is known of the associated metabolic changes. This study aimed to identify characteristic metabolic markers that differentiate severe cases of paediatric TBM from controls, through non-invasive urine collection. Urine samples selected for this study were from two paediatric groups. Group 1: controls (n = 44): children without meningitis, no neurological symptoms and from the same geographical region as group 2. Group 2: TBM cases (n = 13): collected from paediatric patients that were admitted to Tygerberg Hospital in South Africa on the suspicion of TBM, mostly severely ill; with a later confirmation of TBM. Untargeted 1H NMR-based metabolomics data of urine were generated, followed by statistical analyses via MetaboAnalyst (v5.0), and the identification of important metabolites. Twenty nine urinary metabolites were identified as characteristic of advanced TBM and categorized in terms of six dysregulated metabolic pathways: 1) upregulated tryptophan catabolism linked to an altered vitamin B metabolism; 2) perturbation of amino acid metabolism; 3) increased energy production-metabolic burst; 4) disrupted gut microbiota metabolism; 5) ketoacidosis; 6) increased nitrogen excretion. We also provide original biological insights into this biosignature of urinary metabolites that can be used to characterize paediatric TBM patients in a South African cohort.
Related Concept Videos
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...

